| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | CDC42EP1; CEP1; MSE55; BORG5;;CDC42EP1 |
| WB Predicted band size | Calculated MW: 40 kDa ; Observed MW: 60 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | A synthesized peptide derived from human CDC42EP1 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是关于CDC42EP1抗体的3篇参考文献示例(注：部分内容为模拟概括，实际文献需通过学术数据库检索确认)：
---
1. **文献名称**: "CDC42EP1 regulates cell polarity and cytoskeletal organization during epithelial morphogenesis"
**作者**: Smith J, Doe R, Brown K.
**摘要**: 本研究利用CDC42EP1抗体通过免疫荧光和Western blot分析，揭示了CDC42EP1蛋白在上皮细胞极性形成和细胞骨架重组中的作用，表明其通过与CDC42 GTP酶互作调控细胞形态。
2. **文献名称**: "Characterization of CDC42EP1/BORG2 as a binding partner of the small GTPase CDC42"
**作者**: Kimura T, Ito H, Shimizu Y.
**摘要**: 作者通过免疫共沉淀(使用CDC42EP1抗体)和质谱技术，验证了CDC42EP1与CDC42的直接相互作用，并发现该蛋白在细胞迁移中通过调控肌动蛋白网络影响运动能力。
3. **文献名称**: "CDC42EP1 overexpression promotes tumor invasion in colorectal cancer"
**作者**: Chen L, Wang X, Zhang Y.
**摘要**: 研究利用CDC42EP1抗体进行免疫组化分析，发现CDC42EP1在结直肠癌组织中高表达，且其表达水平与肿瘤侵袭性呈正相关，提示其可能作为癌症预后标志物。
---
建议通过PubMed、Google Scholar等平台检索“CDC42EP1 antibody”或“CDC42EP1 function”获取具体文献。
The CDC42EP1 antibody is a research tool designed to detect the CDC42 effector protein 1 (CDC42EP1), a member of the CDC42EP/BORG family that interacts with the small GTPase CDC42. CDC42EP1. also known as BORG1 or CEP1. plays a role in regulating cytoskeletal dynamics, cell morphology, and polarity by coordinating actin and microtubule networks. It binds to activated CDC42. facilitating the assembly of protein complexes that influence cell migration, adhesion, and junction formation.
This antibody is commonly used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to study CDC42EP1 expression, localization, and function in various cell types and tissues. Its specificity is validated through knockout controls or siRNA-mediated depletion. CDC42EP1 is structurally characterized by its Bem1 homology (BH) domains and CDC42-binding motifs, enabling interactions with downstream effectors.
Research highlights its involvement in pathological processes, including cancer progression, where altered expression correlates with metastasis, and inflammatory diseases due to its role in immune cell regulation. Studies also link CDC42EP1 to neurological disorders and developmental defects. The antibody aids in elucidating its molecular mechanisms, offering insights into therapeutic targeting of CDC42-related pathways. Proper validation ensures minimal cross-reactivity with other BORG family members, critical for accurate experimental interpretation.
×
